November 21, 2026Funding-Series BSpace

Ramon.Space Raises $124M Series B to Put Data Centers in Orbit, One Node at a Time

Satellites collect far more data than they can send down. Ramon.Space sells the fix: computers that survive radiation and process data in orbit. The Denver-based company, with Israeli roots, raised a $124M Series B led by growth equity firm PSG, bringing its total raised to about $180M. New investors are Micron Technology, Senvest and Phoenix Financial; StageOne, Deep Insight and Grove Ventures returned. No valuation disclosed. Announced Nov 17, it is a catch-up item here: the round ranked fifth on Crunchbase's weekly biggest-rounds list published inside this window. Coverage: https://satnews.com/2026/11/17/ramon-space-raises-124-million-series-b-to-scale-orbital-computing-infrastructure/

The jump in size tells the story. The previous Series B in 2023 was about $26M, and total funding stood near $43.5M before this round. Now the plan is to scale manufacturing toward millions of computing nodes. That is not a satellite part supplier talking; that is a company pitching itself as the compute layer for everything in orbit. PSG managing director Ronen Nir said processing data in orbit is becoming essential to the growth of the space economy. https://satellitetoday.com/finance/2026/11/17/ramon-space-raises-124m-to-power-space-computing-growth

Micron on the cap table is the tell. A memory maker buying in means it wants a design slot in space hardware before the volume shows up, the same pattern as chipmakers buying into AI labs on Earth this week. If orbital data centers and on-board AI inference become real, radiation-tolerant compute is the bottleneck, and Ramon wants to own it.

My read: for an AI reader, this is edge inference in the harshest edge there is. Earth-observation satellites that can run a model up there and send down an answer instead of raw pixels change the economics of every downstream product, from crop monitoring to defense. $124M says investors think that shift is close enough to need factories.
← Previous
Marrow Therapeutics Launches With $173M Series A and B to Deliver Drugs Straight to Bone Marrow
Next β†’
Super User Daily: 2026-11-21
← Back to all articles

Comments

Loading...
>_